Can Fite Biopharma Ltd Company Profile (NASDAQ:CANF)

About Can Fite Biopharma Ltd

Can Fite Biopharma Ltd logoCan Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Company's drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CANF
  • CUSIP:
Key Metrics:
  • Previous Close: $2.48
  • 50 Day Moving Average: $2.22
  • 200 Day Moving Average: $2.54
  • 52-Week Range: $1.60 - $7.85
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.88
  • P/E Growth: 0.00
  • Market Cap: $34.08M
  • Outstanding Shares: 13,740,000
Additional Links:

Analyst Ratings

Consensus Ratings for Can Fite Biopharma Ltd (NASDAQ:CANF) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00 (142.42% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetDetails
8/29/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for Can Fite Biopharma Ltd (NASDAQ:CANF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/31/2016Q116($0.09)($0.12)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Can Fite Biopharma Ltd (NASDAQ:CANF)
Current Year EPS Consensus Estimate: $-0.370 EPS
Next Year EPS Consensus Estimate: $-0.360 EPS

Dividends

Dividend History for Can Fite Biopharma Ltd (NASDAQ:CANF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Can Fite Biopharma Ltd (NASDAQ:CANF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Can Fite Biopharma Ltd (NASDAQ:CANF)
DateHeadline
News IconCan-Fite BioPharma reports financial results, provides update on drug development programs (NASDAQ:CANF)
www.news-medical.net - August 27 at 9:04 AM
seekingalpha.com logoCan-Fite Biopharma revenues up 33% in 1H16 (NASDAQ:CANF)
seekingalpha.com - August 26 at 12:06 PM
streetinsider.com logoCan-Fite BioPharma (CANF) Posts Wider Net Loss in H116 (NASDAQ:CANF)
www.streetinsider.com - August 26 at 12:06 PM
baystreet.ca logoCan-Fite Catapults NASH Indication Into Phase II Aiming for $35 Billion Market (NASDAQ:CANF)
www.baystreet.ca - July 28 at 12:49 PM
benzinga.com logoMid-Morning Market Update: Markets Open Lower; Tesla's Deliveries Hit Near 2-Year Low (NASDAQ:CANF)
www.benzinga.com - July 5 at 4:01 PM
seekingalpha.com logoCan-Fite Bio's lead product candidate flunks mid-stage glaucoma study; shares down 23% premarket (NASDAQ:CANF)
seekingalpha.com - July 5 at 4:01 PM
finance.yahoo.com logoCan-Fite Reports New Data Showing its Psoriasis Drug May Offer Efficacy Similar to Industry Leading Biologics Without Harmful Side Effects (NASDAQ:CANF)
finance.yahoo.com - June 15 at 4:08 PM
streetinsider.com logoCan-Fite BioPharma (CANF) Announces New Data Showing CF101 May Offer Efficacy Similar to Leading Biologics Without Harmful Side Effects (NASDAQ:CANF)
www.streetinsider.com - June 15 at 4:08 PM
seekingalpha.com logoCan-Fite finalizes design of late-stage study of CF101 in rheumatoid arthritis, enrollment to start no later than Q3 (NASDAQ:CANF)
seekingalpha.com - June 3 at 8:20 AM
News IconNew migraine drugs promise relief — but at a steep price - The Verge (NASDAQ:CANF)
www.theverge.com - May 25 at 2:50 PM
News IconBroker Roundup For Can-Fite Biopharma Ltd (CANF) - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - May 19 at 2:36 PM
News IconAnalysts Expect Can Fite Biopharma Ltd (NASDAQ:CANF) to Post ($0.09) EPS - Washington News Wire (NASDAQ:CANF)
washingtonnewswire.com - May 12 at 9:34 AM
News IconBroker Outlook For Can-Fite Biopharma Ltd (CANF) - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - May 7 at 8:36 AM
streetinsider.com logoCan-Fite BioPharma (CANF) Will Present CF602 Data at AUA 2016 - StreetInsider.com (NASDAQ:CANF)
www.streetinsider.com - May 2 at 9:17 AM
finance.yahoo.com logoCan-Fite to Present Data on CF602 in the Treatment of Erectile Dysfunction at American Urology Association's Annual Meeting (NASDAQ:CANF)
finance.yahoo.com - May 2 at 7:00 AM
finance.yahoo.com logoCan-Fite to Present at Joseph Gunnar & Co.'s Pioneers 2016 Conference in New York City on May 5, 2016 (NASDAQ:CANF)
finance.yahoo.com - April 29 at 7:00 AM
News IconCan-Fite Biopharma Ltd (CANF) Latest Broker Coverage - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - April 14 at 2:28 PM
News IconRecently Changed Price Targets On Can-Fite Biopharma Ltd (CANF) - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - April 13 at 3:09 PM
News IconCan-Fite Biopharma Ltd (CANF) Analyst Review - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - April 13 at 3:09 PM
News IconLatest Analyst Ratings For Can-Fite Biopharma Ltd (CANF) - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - April 13 at 3:09 PM
News IconCan-Fite Biopharma Ltd (CANF) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - April 12 at 1:03 PM
wallstrt24.com logoUnitedHealth Group (NYSE:UNH) & Can Fite Biopharma (NYSEMKT:CANF) Investor's Watch List - Wall Street 24 (NASDAQ:CANF)
wallstrt24.com - April 12 at 1:03 PM
streetinsider.com logoCan-Fite BioPharma (CANF) Announces Positive New Pre-Clinical Data for CF602 - StreetInsider.com (NASDAQ:CANF)
www.streetinsider.com - April 12 at 1:03 PM
News IconAnalyst Review: Can-Fite Biopharma Ltd (CANF) - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - April 9 at 12:30 PM
wallstrt24.com logoVersartis (NASDAQ:VSAR) & Can Fite Biopharma (NYSEMKT:CANF) Notable Runners - Wall Street 24 (NASDAQ:CANF)
wallstrt24.com - April 5 at 2:38 PM
News IconCan-Fite Biopharma Ltd (CANF) Latest Broker Views - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - April 1 at 3:00 PM
streetinsider.com logoForm 6-K Can-Fite BioPharma Ltd. For: Apr 01 - StreetInsider.com (NASDAQ:CANF)
www.streetinsider.com - April 1 at 3:00 PM
News IconAfter Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF) - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - March 30 at 2:27 PM
News IconUpdated Price Targets On Can-Fite Biopharma Ltd (CANF) - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - March 25 at 3:01 PM
News IconPrice Target Update: Can-Fite Biopharma Ltd (CANF) - SCSUCollegian (NASDAQ:CANF)
www.thescsucollegian.com - March 25 at 3:01 PM
News IconCan-Fite Biopharma Ltd (CANF): What Do Brokers Think For The Coming Week? - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - March 20 at 2:41 PM
News IconAfter Last Week What Do Analysts Think Of Can-Fite Biopharma Ltd (CANF)? - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - March 20 at 2:41 PM
News IconPotter and Penniman: “The System Is Rigged Against Regular People” - BillMoyers.com (NASDAQ:CANF)
billmoyers.com - March 19 at 12:44 PM
streetinsider.com logoCan-Fite BioPharma (CANF) Submits EMA Protocol Design for Phase III Trial of Lead Compound CF101 - StreetInsider.com (NASDAQ:CANF)
www.streetinsider.com - March 18 at 2:19 PM
News IconMaking Impressive Motion: Can-Fite BioPharma (NYSEMKT:CANF), Dynatronics Corp. (NASDAQ:DYNT), Whiting ... - Property Mentor (NASDAQ:CANF)
www.propertymentorgroup.com - March 17 at 2:03 PM
News IconCan-Fite Biopharma Ltd (CANF) New Analyst Ratings - Share Trading News (NASDAQ:CANF)
www.sharetrading.news - March 17 at 2:03 PM
News IconThe Latest: Clinton says foreign leaders wary of Trump - WKOW (NASDAQ:CANF)
www.wkow.com - March 14 at 8:13 AM
News IconThe CNN Miami Republican debate transcript, annotated - Washington Post (NASDAQ:CANF)
www.washingtonpost.com - March 12 at 1:41 PM
nytimes.com logoTranscript of the Republican Presidential Debate in Florida - New York Times (NASDAQ:CANF)
www.nytimes.com - March 12 at 1:41 PM
cnn.com logoTranscript of Republican debate in Miami, full text - CNN International (NASDAQ:CANF)
www.cnn.com - March 12 at 1:41 PM
News IconCan-Fite Biopharma Ltd (CANF) Price Target Changes - Risers & Fallers (NASDAQ:CANF)
www.risersandfallers.com - March 12 at 1:41 PM
News IconThere Is No FDA For Education. Maybe There Should Be - NPR (NASDAQ:CANF)
www.npr.org - March 9 at 2:56 PM
News IconActive Stocks Need to Consider: Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Micsurgedmi Corporation (NASDAQ ... - Seneca Globe (NASDAQ:CANF)
www.senecaglobe.com - March 4 at 2:57 PM
News IconStocks Preparing To Gain Concentrations: Can-Fite BioPharma (CANF), Micsurgedmi (MSCC), Sotheby's (OFFER) - Seneca Globe (NASDAQ:CANF)
www.senecaglobe.com - March 4 at 2:57 PM
News IconTaylor Sheridan On The Drug War And His Evolution From 'Sons Of Anarchy' Actor To 'Sicario' Screenwriter - UPROXX (NASDAQ:CANF)
uproxx.com - March 3 at 2:53 PM
investorplace.com logoHottest Manufacturing Stocks Now - CRMD TUMI JOY TSE - Investorplace.com (NASDAQ:CANF)
investorplace.com - March 3 at 2:53 PM
prnewswire.com logoCan-Fite to Present Psoriasis Data at American Academy of Dermatology's 74th Annual Meeting in Washington D.C. on ... - PR Newswire (press release) (NASDAQ:CANF)
www.prnewswire.com - March 3 at 2:53 PM
bloomberg.com logoVodafone Unit Scraps Neotel Deal After Two-Year Regulatory Fight - Bloomberg (NASDAQ:CANF)
www.bloomberg.com - March 2 at 2:47 PM
News IconOpinion: Republicans slide towards existential crisis - Deutsche Welle (NASDAQ:CANF)
www.dw.com - March 2 at 2:47 PM
News IconStocks on the Move: Alphabet Inc (NASDAQ:GOOG), American Airlines Group Inc. (NASDAQ:AAL), Can-Fite ... - Property Mentor (NASDAQ:CANF)
www.propertymentorgroup.com - February 29 at 2:30 PM

Social

Can Fite Biopharma Ltd (NASDAQ:CANF) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff